Ning Dong Selected Research

alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamide

3/2009	Inhibition of Janus kinase 2 and signal transduction and activator of transcription 3 protect against cecal ligation and puncture-induced multiple organ damage and mortality.
7/2006	[The potential mechanism on signal transduction pathway in regulation of mRNA expression of high mobility group box-1 protein in septic rats].
3/2003	[Potential role of JAK/STAT in regulating Toll-like receptor 2 gene expression in rats with postburn Staphylococcus aureus sepsis].
3/2003	[Role of Janus kinase/signal transducer and activator of transcription pathway in mediating mRNA expression of high mobility group box1 protein in the liver in septic rats].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ning Dong Research Topics

Disease

44	Sepsis (Septicemia) 01/2022 - 04/2002
28	Burns 01/2019 - 01/2003
18	Inflammation (Inflammations) 01/2021 - 07/2006
15	Infections 06/2022 - 11/2003
8	Neoplasms (Cancer) 01/2022 - 11/2017
7	Poisoning 01/2021 - 05/2013
6	Multiple Organ Failure (MODS) 09/2014 - 04/2003
5	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2019 - 11/2012
4	Macular Edema 04/2018 - 01/2013
4	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 04/2016 - 05/2013
4	Cataract (Cataracts) 01/2015 - 01/2013
3	Heart Failure 01/2022 - 01/2013
3	Organophosphate Poisoning 01/2021 - 01/2020
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2018
3	Hyperglycemia 01/2020 - 02/2018
3	Osteoarthritis 01/2020 - 01/2019
3	Osteonecrosis (Kienbock's Disease) 01/2020 - 12/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021 - 05/2021
2	Lung Neoplasms (Lung Cancer) 06/2021 - 11/2017
2	Wounds and Injuries (Trauma) 01/2021 - 01/2019
2	Pneumonia (Pneumonitis) 01/2021 - 01/2018
2	Ischemic Stroke 01/2021 - 01/2014
2	Heart Arrest (Cardiac Arrest) 01/2021 - 04/2016
2	Hypotension (Low Blood Pressure) 01/2021 - 01/2021
2	Salmonella Infections (Salmonellosis) 01/2019 - 01/2018
2	Diabetes Mellitus 12/2018 - 11/2012
2	Type 2 Diabetes Mellitus (MODY) 04/2018 - 01/2013
2	Brain Injuries (Brain Injury) 11/2017 - 04/2016
2	Retinal Vein Occlusion 06/2014 - 11/2013
2	Hyperplasia 01/2013 - 07/2012
2	Staphylococcal Infections 04/2004 - 03/2003

Drug/Important Bio-Agent (IBA)

21	HMGB1 Protein (HMG1)IBA 01/2021 - 03/2003
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
16	CytokinesIBA 01/2022 - 11/2003
14	salicylhydroxamic acid (SHAM)IBA 10/2021 - 04/2003
8	Carbapenems (Carbapenem Antibiotics)IBA 06/2022 - 01/2018
8	Messenger RNA (mRNA)IBA 01/2019 - 04/2002
7	Biomarkers (Surrogate Marker)IBA 06/2021 - 01/2014
6	Interleukin-2 (IL2)IBA 01/2011 - 01/2005
6	ethyl pyruvateIBA 07/2010 - 01/2005
5	Colistin (Coly-Mycin)FDA Link 06/2022 - 07/2018
5	Sirolimus (Rapamycin)FDA Link 01/2017 - 03/2003
5	Carbon MonoxideIBA 04/2016 - 05/2013
5	GelsolinIBA 02/2016 - 01/2011
4	Tigecycline (Tygacil)FDA Link 06/2022 - 07/2018
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2018
4	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2014
4	LipopolysaccharidesIBA 10/2020 - 04/2010
4	Retinaldehyde (Retinal)IBA 11/2019 - 11/2012
4	EndotoxinsIBA 01/2018 - 04/2002
4	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 03/2009 - 03/2003
4	Janus KinasesIBA 03/2009 - 03/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 04/2004
3	Indicators and Reagents (Reagents)IBA 06/2021 - 03/2018
3	Advanced Oxidation Protein Products (AOPP)IBA 01/2021 - 01/2020
3	InterleukinsIBA 10/2020 - 01/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2013
3	AdipokinesIBA 01/2020 - 01/2018
3	HomocysteineIBA 04/2018 - 11/2013
3	XuebijingIBA 01/2015 - 01/2006
3	Interleukin-10 (Interleukin 10)IBA 01/2015 - 03/2009
3	HLA-DR Antigens (HLA-DR)IBA 09/2008 - 01/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022 - 01/2021
2	Neuroprotective AgentsIBA 01/2021 - 05/2013
2	Cholinesterases (Cholinesterase)IBA 01/2021 - 01/2021
2	Advanced Glycation End ProductsIBA 01/2020 - 03/2009
2	LeptinIBA 01/2020 - 01/2018
2	S100A12 ProteinIBA 11/2019 - 07/2015
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 02/2018
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2019 - 01/2018
2	Exenatide (Byetta)FDA Link 01/2019 - 02/2018
2	Streptozocin (Streptozotocin)FDA Link 12/2018 - 11/2012
2	NucleotidesIBA 10/2018 - 11/2017
2	Adenosine Triphosphate (ATP)IBA 10/2018 - 11/2017
2	Erythropoietin FDA Link 04/2016 - 05/2013
2	Vasopressins (Vasopressin)IBA 04/2016 - 09/2014
2	ImmunosorbentsIBA 01/2015 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 01/2013
2	EnzymesIBA 01/2015 - 01/2014
2	Interleukin-12 (IL 12)IBA 01/2015 - 07/2010
2	NitrogenIBA 09/2014 - 03/2006
2	CreatinineIBA 09/2014 - 03/2006
2	Urea (Carbamide)FDA LinkGeneric 09/2014 - 03/2006
2	Biological ProductsIBA 01/2014 - 08/2003
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014 - 11/2012
2	Lipopolysaccharide ReceptorsIBA 05/2009 - 04/2009
2	MitogensIBA 04/2009 - 07/2005
2	BiopterinsIBA 08/2003 - 11/2002
2	5-dehydro-3-deoxy-D-arabino-heptulosonic acid-7-phosphate (DAHP)IBA 11/2002 - 04/2002

Therapy/Procedure

11	Punctures 01/2022 - 03/2003
11	Ligation 01/2022 - 03/2003
6	Therapeutics 05/2021 - 01/2003
5	Resuscitation 01/2022 - 01/2005
2	Immunotherapy 06/2021 - 05/2021
2	Mechanical Ventilators (Ventilator) 01/2021 - 02/2012
2	Arthroplasty 01/2020 - 02/2017
2	Lasers (Laser) 01/2019 - 01/2018
2	Artificial Respiration (Mechanical Ventilation) 01/2018 - 02/2012
2	Hip Replacement Arthroplasty (Total Hip Replacement) 02/2017 - 12/2016
2	Phacoemulsification 01/2015 - 01/2013